Give short acting BDs SABA albuterol levalbuterol MDI NEB SAMA ipratropium MDI NEB C Use NEB hourly x2 3 doses then q2 4h Continuous NEB not recommended Air driven NEB preferred vs O2 driven to avoid potential uarr PaCO2 Use standard COVID 19 precautions

By rray, 29 January, 2024
Exclude Patient Type Detail Header
No
Detail Type
Text
Patient Type Detail Header (Long)
<b>Give short-acting BDs:</b> SABA (<a href=https://online.epocrates.com/e/deeplink/drugs/10a3308/albuterol%20inhaled><u>albuterol</u></a>, levalbuterol (<a href=https://online.epocrates.com/e/deeplink/drugs/10a4146/Xopenex%20HFA><u>MDI</u></a>, <a href=https://online.epocrates.com/e/deeplink/drugs/10a2202/levalbuterol%20inhaled><u>NEB</u></a>)) +/- SAMA (ipratropium (<a href=https://online.epocrates.com/e/deeplink/drugs/10a4060/Atrovent%20HFA><u>MDI</u></a>, <a href=https://online.epocrates.com/e/deeplink/drugs/10a418/ipratropium%20bromide%20inhaled><u>NEB</u></a>)) [C]. Use NEB hourly x2-3 doses, then q2-4h. Continuous NEB <b>not recommended</b>. Air-driven NEB preferred vs. O<sub>2</sub>-driven to avoid potential &uarr;PaCO<sub>2</sub>. Use standard COVID-19 precautions; keep circuit intact; use mesh NEB in ventilated pts.